Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$454.43 - $535.6 $2.73 Million - $3.21 Million
-6,000 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$334.87 - $493.06 $5.59 Million - $8.23 Million
-16,700 Reduced 73.57%
6,000 $2.71 Million
Q1 2020

May 12, 2020

BUY
$320.01 - $409.07 $2.78 Million - $3.56 Million
8,700 Added 62.14%
22,700 $7.96 Million
Q4 2019

Feb 11, 2020

BUY
$319.73 - $374.2 $4.48 Million - $5.24 Million
14,000 New
14,000 $5.18 Million
Q2 2019

Aug 13, 2019

SELL
$286.93 - $312.59 $3.73 Million - $4.06 Million
-13,000 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$224.3 - $317.41 $2.92 Million - $4.13 Million
13,000 New
13,000 $3.97 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.68B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Mufg Securities Emea PLC Portfolio

Follow Mufg Securities Emea PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Securities Emea PLC with notifications on news.